Cancer Management and Research Dovepress Dna Repair in Cancer: Emerging Targets for Personalized Therapy

No abstract is available for this paper.

• Publication year

  year unknown

• Venue

  Unknown venue

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Mutations in ERCC4, encoding the DNA-repair endonuclease XPF, cause Fanconi anemia.

  2013cited by this paper
• DNA Double Strand Break Repair: A Radiation Perspective

  2013cited by this paper
• DNA Ligase IV and Artemis Act Cooperatively to Suppress Homologous Recombination in Human Cells: Implications for DNA Double-Strand Break Repair

  2013cited by this paper
• PARP Inhibition Sensitizes to Low Dose-Rate Radiation TMPRSS2-ERG Fusion Gene-Expressing and PTEN-Deficient Prostate Cancer Cells

  2013cited by this paper
• Synthetic Lethal Targeting of PTEN-Deficient Cancer Cells Using Selective Disruption of Polynucleotide Kinase/Phosphatase

  2013cited by this paper
• DNA double-strand–break complexity levels and their possible contributions to the probability for error-prone processing and repair pathway choice

  2013cited by this paper
• The poly(ADP-ribose) polymerase inhibitor niraparib (MK4827) in BRCA mutation carriers and patients with sporadic cancer: a phase 1 dose-escalation trial.

  2013cited by this paper
• Targeting XRCC1 deficiency in breast cancer for personalized therapy.

  2013cited by this paper
• Functions of Translesion DNA Polymerases: Implications for Cancer Risk and Opportunities as Therapeutic Targets

  2013cited by this paper
• Synergistic Effect of Olaparib with Combination of Cisplatin on PTEN-Deficient Lung Cancer Cells

  2012cited by this paper
• Trapping of PARP1 and PARP2 by Clinical PARP Inhibitors.

  2012cited by this paper
• Enhanced cytotoxicity of PARP inhibition in mantle cell lymphoma harbouring mutations in both ATM and p53

  2012cited by this paper
• Chromatin dynamics in DNA double-strand break repair.

  2012cited by this paper
• Targeting the DNA damage response in oncology: past, present and future perspectives

  2012cited by this paper
• Role of PARP inhibitors in cancer biology and therapy.

  2012cited by this paper
• Synthetic lethal targeting of DNA double‐strand break repair deficient cells by human apurinic/apyrimidinic endonuclease inhibitors

  2012cited by this paper
• DNA double-strand break repair within heterochromatic regions.

  2012cited by this paper
• Biological relevance of DNA polymerase β and translesion synthesis polymerases to cancer and its treatment.

  2012cited by this paper
• PTEN in DNA damage repair.

  2012cited by this paper
• A Germline Polymorphism of DNA Polymerase Beta Induces Genomic Instability and Cellular Transformation

  2012cited by this paper
• DNA interstrand crosslink repair and cancer

  2011cited by this paper
• Treatment with olaparib in a patient with PTEN-deficient endometrioid endometrial cancer

  2011cited by this paper
• Induction and repair of DNA double strand breaks: the increasing spectrum of non-homologous end joining pathways.

  2011cited by this paper
• Variation in base excision repair capacity.

  2011cited by this paper
• PTEN Deletion in Prostate Cancer Cells Does Not Associate with Loss of RAD51 Function: Implications for Radiotherapy and Chemotherapy

  2011cited by this paper
• Stumbling blocks on the path to personalized medicine in breast cancer: the case of PARP inhibitors for BRCA1/2-associated cancers.

  2011cited by this paper
• PARP inhibitors--current status and the walk towards early breast cancer.

  2011cited by this paper
• Mechanism of RAD51-Dependent DNA Interstrand Cross-Link Repair

  2011cited by this paper
• Iniparib Nonselectively Modifies Cysteine-Containing Proteins in Tumor Cells and Is Not a Bona Fide PARP Inhibitor

  2011cited by this paper
• Olaparib in patients with recurrent high-grade serous or poorly differentiated ovarian carcinoma or triple-negative breast cancer: a phase 2, multicentre, open-label, non-randomised study.

  2011cited by this paper
• The underlying mechanism for the PARP and BRCA synthetic lethality: Clearing up the misunderstandings

  2011cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial

  2011cited by this paper
• Germline mutations in RAD51D confer susceptibility to ovarian cancer

  2011cited by this paper
• MRE11 deficiency increases sensitivity to poly(ADP-ribose) polymerase inhibition in microsatellite unstable colorectal cancers.

  2011cited by this paper
• The mechanism of double-strand DNA break repair by the nonhomologous DNA end-joining pathway.

  2010cited by this paper
• Therapeutic Targeting of the DNA Mismatch Repair Pathway

  2010cited by this paper
• 53BP1 loss rescues BRCA1 deficiency and is associated with triple-negative and BRCA-mutated breast cancers

  2010cited by this paper
• Targeting poly(ADP-ribose) polymerase activity for cancer therapy

  2010cited by this paper
• Aurora-A expressing tumour cells are deficient for homology-directed DNA double strand-break repair and sensitive to PARP inhibition

  2010cited by this paper
• Poly (ADP-ribose) polymerase (PARP) is not involved in base excision repair but PARP inhibition traps a single-strand intermediate

  2010cited by this paper
• DNA Polymerases as Potential Therapeutic Targets for Cancers Deficient in the DNA Mismatch Repair Proteins MSH2 or MLH1

  2010cited by this paper
• Collaboration and competition between DNA double‐strand break repair pathways

  2010cited by this paper
• Mismatch repair deficient colorectal cancer in the era of personalized treatment

  2010cited by this paper
• Regulation of damage recognition in mammalian global genomic nucleotide excision repair.

  2010cited by this paper
• PTEN loss compromises homologous recombination repair in astrocytes: implications for glioblastoma therapy with temozolomide or poly(ADP-ribose) polymerase inhibitors.

  2010cited by this paper
• Biology-driven cancer drug development: back to the future

  2010cited by this paper
• Development of a Functional Assay for Homologous Recombination Status in Primary Cultures of Epithelial Ovarian Tumor and Correlation with Sensitivity to Poly(ADP-Ribose) Polymerase Inhibitors

  2010cited by this paper
• PPM1D gene amplification and overexpression in breast cancer: a qRT-PCR and chromogenic in situ hybridization study

  2010cited by this paper
• Synthetic lethal interactions for the development of cancer therapeutics: biological and methodological advancements

  2010cited by this paper
• PTEN Deficiency in Endometrioid Endometrial Adenocarcinomas Predicts Sensitivity to PARP Inhibitors

  2010cited by this paper
• Somatic mutations in BRCA1 and BRCA2 could expand the number of patients that benefit from poly (ADP ribose) polymerase inhibitors in ovarian cancer.

  2010cited by this paper
• An integrative genomic and transcriptomic analysis reveals molecular pathways and networks regulated by copy number aberrations in basal-like, HER2 and luminal cancers

  2010cited by this paper
• Human AP endonuclease 1 (APE1): from mechanistic insights to druggable target in cancer.

  2010cited by this paper
• Sensitization to Radiation and Alkylating Agents by Inhibitors of Poly(ADP-ribose) Polymerase Is Enhanced in Cells Deficient in DNA Double-Strand Break Repair

  2010cited by this paper
• DNA repair signature is associated with anthracycline response in triple negative breast cancer patients

  2010cited by this paper
• Role of homologous recombination in DNA interstrand crosslink repair

  2010cited by this paper
• PISA, a novel pharmacodynamic assay for assessing poly(ADP-ribose) polymerase (PARP) activity in situ.

  2010cited by this paper
• First-in-human trial of a poly(ADP)-ribose polymerase (PARP) inhibitor MK-4827 in advanced cancer patients with antitumor activity in BRCA-deficient tumors and sporadic ovarian cancers (soc).

  2010cited by this paper
• Gene expression profile of BRCAness that correlates with responsiveness to chemotherapy and with outcome in patients with epithelial ovarian cancer.

  2010cited by this paper
• Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.

  2010cited by this paper
• Synthetic lethal approaches to breast cancer therapy

  2010cited by this paper
• Translesion DNA synthesis polymerases in DNA interstrand crosslink repair

  2010cited by this paper
• Molecular and Cellular Pathobiology Cancer Research Poly ( ADP-Ribose ) Polymerase Is Hyperactivated in Homologous Recombination – Defective Cells

  2010cited by this paper
• Inhibition of poly(ADP-ribose) polymerase in tumors from BRCA mutation carriers.

  2009cited by this paper
• V(D)J recombination deficiencies.

  2009cited by this paper
• Going Ape as an Approach to Cancer Therapeutics

  2009cited by this paper
• Genomic instability and the selection of treatments for cancer

  2009cited by this paper
• Fork regression is an active helicase‐driven pathway in bacteriophage T4

  2009cited by this paper
• Integrated Functional, Gene Expression and Genomic Analysis for the Identification of Cancer Targets

  2009cited by this paper
• Essential role of DNA base excision repair on survival in an acidic tumor microenvironment.

  2009cited by this paper
• Repair of ionizing radiation-induced DNA double-strand breaks by non-homologous end-joining.

  2009cited by this paper
• Synthetic lethal targeting of PTEN mutant cells with PARP inhibitors

  2009cited by this paper
• Cell cycle checkpoint defects contribute to genomic instability in PTEN deficient cells independent of DNA DSB repair

  2009cited by this paper
• Phase I Study of the Poly(ADP-Ribose) Polymerase Inhibitor, AG014699, in Combination with Temozolomide in Patients with Advanced Solid Tumors

  2008cited by this paper
• The fidelity of DNA synthesis by eukaryotic replicative and translesion synthesis polymerases

  2008cited by this paper
• Single-strand break repair and genetic disease

  2008cited by this paper
• Eukaryotic nucleotide excision repair: from understanding mechanisms to influencing biology

  2008cited by this paper
• E2F1 Regulates the Base Excision Repair Gene XRCC1 and Promotes DNA Repair*

  2008cited by this paper
• The nuclear affairs of PTEN

  2008cited by this paper
• Current topics in DNA double-strand break repair.

  2008cited by this paper
• Targeted therapy for cancer using PARP inhibitors.

  2008cited by this paper
• MMEJ repair of double-strand breaks (director's cut): deleted sequences and alternative endings.

  2008cited by this paper
• Resistance to therapy caused by intragenic deletion in BRCA2

  2008cited by this paper
• PTEN: a new guardian of the genome

  2008cited by this paper
• Secondary mutations as a mechanism of cisplatin resistance in BRCA2-mutated cancers

  2008cited by this paper
• A high-throughput RNA interference screen for DNA repair determinants of PARP inhibitor sensitivity.

  2008cited by this paper
• Mechanisms and functions of DNA mismatch repair

  2008cited by this paper
• DNA double-strand break repair: from mechanistic understanding to cancer treatment.

  2007cited by this paper
• Adenoviral-mediated PTEN expression radiosensitizes non-small cell lung cancer cells by suppressing DNA repair capacity

  2007cited by this paper
• Involvement of Ku80 in microhomology-mediated end joining for DNA double-strand breaks in vivo.

  2007cited by this paper
• Essential role for nuclear PTEN in maintaining chromosomal integrity.

  2007cited by this paper
• Combining carefully selected drug, patient genetics may lead to total tumor death.

  2007cited by this paper
• Deficiency in incisions produced by XPF at the site of a DNA interstrand cross-link in Fanconi anemia cells.

  2007cited by this paper
• ABT-888, an Orally Active Poly(ADP-Ribose) Polymerase Inhibitor that Potentiates DNA-Damaging Agents in Preclinical Tumor Models

  2007cited by this paper
• Human base excision repair complex is physically associated to DNA replication and cell cycle regulatory proteins

  2007cited by this paper
• A backup DNA repair pathway moves to the forefront.

  2007cited by this paper
• Mechanisms of eukaryotic DNA double strand break repair.

  2006cited by this paper
• First and final report of a phase II study of the poly(ADP-ribose) polymerase (PARP) inhibitor, AG014699, in combination with temozolomide (TMZ) in patients with metastatic malignant melanoma (MM).

  2006cited by this paper
• DNA double-strand break repair: all's well that ends well.

  2006cited by this paper
• Chk2 Mediates Stabilization of the FoxM1 Transcription Factor To Stimulate Expression of DNA Repair Genes

  2006cited by this paper

• The Current Status of DNA-Repair-Directed Precision Oncology Strategies in Epithelial Ovarian Cancers

  2023influential citation
• Triptolide enhances carboplatin-induced apoptosis by inhibiting nucleotide excision repair (NER) activity in melanoma

  2023cites this paper
• DNA Double-Strand Break-Related Competitive Endogenous RNA Network of Noncoding RNA in Bovine Cumulus Cells

  2023cites this paper
• Current understanding of adenoid cystic carcinoma in the gene expression and targeted therapy

  2023cites this paper
• Evolving DNA repair synthetic lethality targets in cancer

  2022cites this paper
• Inborn Errors of Immunity and Cancer

  2021cites this paper
• Nano-Delivery of a Novel Inhibitor of Polynucleotide Kinase/Phosphatase (PNKP) for Targeted Sensitization of Colorectal Cancer to Radiation-Induced DNA Damage

  2021cites this paper
• Versatile Cell-Based Assay for Measuring Base Excision Repair of DNA Alkylation Damage

  2021cites this paper
• Versatile cell-based assay for measuring DNA alkylation damage and its repair

  2021cites this paper
• Impact of Hypoxia on Relative Biological Effectiveness and Oxygen Enhancement Ratio for a 62-MeV Therapeutic Proton Beam

  2021cites this paper
• BBIT20 inhibits homologous DNA repair with disruption of the BRCA1–BARD1 interaction in breast and ovarian cancer

  2021cites this paper
• Synthesis and anti-tumor activity of marine alkaloids.

  2021cites this paper
• Cisplatin Resistance in Osteosarcoma: In vitro Validation of Candidate DNA Repair-Related Therapeutic Targets and Drugs for Tailored Treatments

  2020influential citation
• XRCC1 Gene Polymorphism Increases the Risk of Hepatocellular Carcinoma in Egyptian Population

  2020cites this paper
• Developing a clinically relevant radiosensitizer for temozolomide-resistant gliomas

  2020cites this paper
• Participation of the ATR/CHK1 pathway in replicative stress targeted therapy of high-grade ovarian cancer

  2020cites this paper
• A novel DNA repair‐related nomogram predicts survival in low‐grade gliomas

  2020cites this paper
• Gene expression of DNA repair proteins in colorectal cancer and medulloblastoma

  2019influential citation
• A Systematic Review on Predisposition to Lymphoid (B and T cell) Neoplasias in Patients With Primary Immunodeficiencies and Immune Dysregulatory Disorders (Inborn Errors of Immunity)

  2019cites this paper
• Promoter methylation of DNA damage repair (DDR) genes in human tumor entities: RBBP8/CtIP is almost exclusively methylated in bladder cancer

  2018cites this paper
• Chapter 4 Direct Reversal Repair in Mammalian Cells

  2018cites this paper
• Low penetrance genetic polymorphisms as potential biomarkers for colorectal cancer predisposition

  2018cites this paper
• Synthesis and evaluation of the mutagenicity of 3-alkylpyridine marine alkaloid analogues with anticancer potential.

  2018cites this paper
• A PARP1 és p53 útvonal bioinformatikai és neuropatológiai vizsgálata gliomákban

  2017cites this paper
• Cáncer hereditario y consejo genético oncológico

  2017cites this paper
• Therapeutic potential of HIV nosode 30c as evaluated in A549 lung cancer cells

  2017cites this paper
• The DNA damage response of C. elegans affected by gravity sensing and radiosensitivity during the Shenzhou-8 spaceflight.

  2017cites this paper
• Ataxia-telangiectasia mutated interactor regulates head and neck cancer metastasis via KRas expression.

  2017cites this paper
• Effect of AICAR and 5-Fluorouracil on X-ray Repair, Cross-Complementing Group 1 Expression, and Consequent Cytotoxicity Regulation in Human HCT-116 Colorectal Cancer Cells

  2017cites this paper
• Cytogenotoxicological defense of retinyl palmitate in the front damage of antineoplastics.

  2017cites this paper
• A network-pathway based module identification for predicting the prognosis of ovarian cancer patients

  2016cites this paper
• TRAIL and TRAIL receptors in patients with laryngeal cancer

  2016cites this paper
• Progesterone receptor expression is associated with longer overall survival within high-grade histotypes of endometrial carcinoma: A Canadian high risk endometrial cancer consortium (CHREC) study.

  2016cites this paper
• Targeting CDKs with Roscovitine Increases Sensitivity to DNA Damaging Drugs of Human Osteosarcoma Cells

  2016cites this paper
• A homeopathic nosode, Hepatitis C 30 demonstrates anticancer effect against liver cancer cells in vitro by modulating telomerase and topoisomerase II activities as also by promoting apoptosis via intrinsic mitochondrial pathway.

  2016cites this paper
• Targeted drugs in small-cell lung cancer.

  2016cites this paper
• Estrogen Receptor Expression Is Associated with DNA Repair Capacity in Breast Cancer

  2016cites this paper
• The prognostic value of morphologic findings for lung squamous cell carcinoma patients.

  2016cites this paper
• TEYSUNO™ (S-1) IS BENEFICIAL FOR EGFR-TKI REFRACTORY NSCLC PATIENTS

  2016cites this paper
• Peran Poly (ADP-ribose) Polymerase-1 pada Perbaikan Kerusakan DNA

  2016cites this paper
• The miR-193a-3p regulated PSEN1 gene suppresses the multi-chemoresistance of bladder cancer.

  2015cites this paper
• Effects of microgravity on DNA damage response in Caenorhabditis elegans during Shenzhou-8 spaceflight

  2015cites this paper
• DNA repair in cancer stem cells as a factor for glioma resistance to radiotherapy

  2015cites this paper
• Direct Reversal Repair in Mammalian Cells

  2015cites this paper
• репарация Днк в опухолевых стволовых клетках как фактор развития устойчивости глиом к радиотерапии

  2015cites this paper
• Human targeted deletions and biological roles of genes involved in repair of alkylation damage

  2015cites this paper
• In Vitro Apoptosis Triggering in the BT-474 Human Breast Cancer Cell Line by Lyophilised Camel's Milk.

  2015cites this paper
• Increased in vitro and in vivo sensitivity of BRCA2-associated pancreatic cancer to the poly(ADP-ribose) polymerase-1/2 inhibitor BMN 673.

  2015cites this paper
• Excision repair cross‐complementation group 1 protein expression predicts survival in patients with high‐grade, non‐metastatic osteosarcoma treated with neoadjuvant chemotherapy

  2015cites this paper
• ercc1 protein expression predicts survival in patients with high-grade, non-metastatic osteosarcoma treated with neoadjuvant chemotherapy Short running title: ercc1 clinical impact in high-grade osteosarcoma

  2015cites this paper
• Therapeutic approaches to BRCA 2-associated pancreatic cancer

  2015cites this paper
• Association between XRCC1 Arg280His polymorphism and risk of hepatocellular carcinoma: a systematic review and meta-analysis.

  2015cites this paper
• Association between XRCC 1 Arg 280 His polymorphism and risk of hepatocellular carcinoma : a systematic review and meta-analysis

  2015cites this paper
• The role of specific PP 2 A complexes in the dephosphorylation of c H 2 AX

  2015cites this paper
• Identification and functional characterisation of potential novel cancer-testis genes in human cancer cells

  2014cites this paper
• Avaliação dos efeitos do azul de metileno fotoativado no modelo experimental do Tumor de Walker 256.

  2014cites this paper
• Oxidative DNA damage in disease—Insights gained from base excision repair glycosylase‐deficient mouse models

  2014cites this paper
• Synthesis and Biological Evaluation of Novel 3-Alkylpyridine Marine Alkaloid Analogs with Promising Anticancer Activity

  2014cites this paper